<html lang="EN" xmlns="http://www.w3.org/1999/xhtml">
<head>
	<title>CE OnLine</title>
<link media="screen" href="ceonline.css" rel="stylesheet" type="text/css" />
<script type="text/javascript" src="epoch_classes.js"></script>
<script type="text/javascript">

	var bas_cal;      
window.onload = function () {
	bas_cal = new Epoch('epoch_basic','flat',document.getElementById('basic_container'));
};
/*]]>*/
</script>

</head>
<SCRIPT language=javascript src="/js/text.js"></SCRIPT>

<body>
<!--testata-->
<table width="100%" border="0" align="center" height="108" style="background-image:url('images/sfondo.gif')">
	<tr>
	  <td class="bg">&nbsp;</td>
	</tr>
</table>

<br>



<table class="ricetta" align="center" border="0" width="1000" height="400">
	<tr>
		
		<td class="bgcellea"><img src="images/registro.gif"><br><b>REGISTRO SPERIMENTAZIONI CLINICHE</b></td>
		<td class="bgcelle">Inserisci nuova sperimentazione clinica</td>
		<td class="bgcelle">Monitoraggio/ aggiornamento</td>
		<td class="bgcelle">Cerca sperimentazioni</td>
		<td class="bgcelle">Area documentale e Forum</td>
		<td class="bgcelle">Reporting </td>
	</tr>
	<tr>
		<td valign="top" width="30%">
			<table border="0" width="100%">
				<tr>	
						<td class="bgcelle2" height="40">Dati Utente</td>
				</tr>
				<tr>
		<td class="strumenti" valign="top"><b>Nome:</b> Roberta&nbsp;Joppi
			<br><b>E-mail:</b> roberta.joppi@ulss20.verona.it
			<br><b>Profilo:</b> Segreteria Comitato Etico per la sperimentazione clinica della provincia di Verona </td>
	</tr>
	
	<tr>
		<td class="bgcelle2" height="40">Utility</td>
	</tr>
	<tr>
		<td class="strumenti">Bacheca del CE</td>
	</tr>
	<tr>
		<td class="strumenti">Messaggi</td>
	</tr>
	<tr>
		<td class="strumenti">Contatti</td>
	</tr>
	<tr>
		<td class="strumenti">Calendario</td>
	</tr>
	<tr>
		<td class="strumenti">News</td>
	</tr>
	<tr>
		<td class="strumenti">Link utili</td>
	</tr>
	<tr>
		<td class="strumenti">Help</td>
	</tr>
	
			</table>
		</td>
		
		
		<td colspan="5" class="st_centrale" valign="top"  width="70%">
			
			<table align="center" width="100%" border="0">
				
				<tr>
					<td class="st_centrale1" align="center">&nbsp;</td>
					<td class="st_centrale1" align="center">&nbsp;</td>
				</tr>
				
			</table>
			
				<table align="center" width="100%" border="1">
				<tr>
					<td align="center" class="tabella"><br>Da valutare (6)</td>
					<td align="center" class="tabella"><br>Sospese (3)</td>
					<td align="center" class="tabella"><br>Approvate (2)</td>
					<td align="center" class="tabella"><br><b>In corso (40)</b></td>
					<td align="center" class="tabella"><br>Concluse (5)</td>
				</tr>
				
			</table>
				
			<br>

					<table align="center" width="100%" border="1">
				<tr>
					<td align="left" colspan="10"><br><b>Sperimentazioni cliniche in corso: 40</b></td>
				</tr>
				<tr>	
					<td align="center" class="tabella"><br><b>ID</b></td>
					<td align="center" class="tabella"><br><b>TIPOLOGIA STUDIO</b></td>
					<td align="center" class="tabella"><br><b>EUDRACT NUMBER/<br>CODICE MINISTERO</b></td>
					<td align="center" class="tabella"><br><b>CODICE STUDIO PROMOTORE</b></td>
					<td align="center" class="tabella"><br><b>CODICE STUDIO CE</b></td>
					<td align="center" class="tabella"><br><b>TITOLO STUDIO</b></td>
					<td align="center" class="tabella"><br><b>DATA RICHIESTA PROMOTORE</b></td>
					<td align="center" class="tabella"><br><b>Monitoraggio scientifico</b></td>
					<td align="center" class="tabella"><b>Monitoraggio amministrativo / economico</b></td>
				</tr>
						<tr>	
					<td align="center" class="tabella"><br>345</td>
					<td align="center" class="tabella"><br>Interventistico con farmaci</td>
					<td align="center" class="tabella"><br>2007-002816-25</td>
					<td align="center" class="tabella"><br>MC/PR/033004/002/06</td>
					<td align="center" class="tabella"><br></td>
					<td align="center" class="tabella"><br>Studio multicentrico, multinalzionale, randomizzato, controllato, doppio cieco, double dummy a gruppi paralleli sull'efficacia e tollerabilita' dellá ssociazione precostituita beclometasone dipropionato 250 mcg piu' salbutamolo 100 mcg in HFA pMDI vs. beclometasone dipropionato 250 mcg piu' salbutamolo 100 mcg in CFC pMDI (Clenil Compositum 250) in pazienti adulti con asma non controllato per 12 settimane</td>
					<td align="center" class="tabella"><br>04/06/2007</td>
					<td align="center" class="tabella"><br><img src="images/binocolo.gif"></td>
					<td align="center" class="tabella"><b></b><br><img src="images/calcolatrice.gif"></td>
				</tr>
				<tr>	
					<td align="center" class="tabella"><br>346</td>
					<td align="center" class="tabella"><br>Studio osservazionale</td>
					<td align="center" class="tabella"><br>-</td>
					<td align="center" class="tabella"><br>STOS1547</td>
					<td align="center" class="tabella"><br>SO#1</td>
					<td align="center" class="tabella"><br>Studio osservazionale</td>
					<td align="center" class="tabella"><br>11/09/2007</td>
					<td align="center" class="tabella"><br><img src="images/binocolo.gif"></td>
					<td align="center" class="tabella"><b></b><br><img src="images/calcolatrice.gif"></td>
				</tr>
				<tr>	
					<td align="center" class="tabella"><br>678</td>
					<td align="center" class="tabella"><br>Dispositivo medico</td>
					<td align="center" class="tabella"><br>-</td>
					<td align="center" class="tabella"><br>DSPMED123</td>
					<td align="center" class="tabella"><br>DM#3</td>
					<td align="center" class="tabella"><br>Dispositivo medico</td>
					<td align="center" class="tabella"><br>25/05/2008</td>
					<td align="center" class="tabella"><br><img src="images/binocolo.gif"></td>
					<td align="center" class="tabella"><b></b><br><img src="images/calcolatrice.gif"></td>
				</tr>
				<tr>	
					<td align="center" class="tabella"><br>567</td>
					<td align="center" class="tabella"><br>Interventistico con farmaci</td>
					<td align="center" class="tabella"><br>2006-003772-35</td>
					<td align="center" class="tabella"><br>AURA-6202-006</td>
					<td align="center" class="tabella"><br>-</td>
					<td align="center" class="tabella"><br>Studio di Fase II con PHA-739358 somministrato tramite infusione endovenosa per 24 ore ogni 14 giorni in pazienti con tumore avanzato/metastastatico alla  mammella, ovaio, colon-retto, pancreas, tumore del polmone a piccole o non-piccole cellule</td>
					<td align="center" class="tabella"><br>30/11/2006</td>
					<td align="center" class="tabella"><br><img src="images/binocolo.gif"></td>
					<td align="center" class="tabella"><b></b><br><img src="images/calcolatrice.gif"></td>
				</tr>
					
			</table>
			
			
			</td>
	</tr>
	
	
<tr>
	<td colspan="6" align="left"><a class="percorso" href="home.htm">Torna all'Home Page</a></td>
</tr>


</form>
</body>
</html>
